How do you view the lack of current safety signals encountered in CV outcome trials with PCSK9 inhibitors? What are the implications for lifelong use of these agents?

Name: How do you view the lack of current safety signals encountered in CV outcome trials with PCSK9 inhibitors? What are the implications for lifelong use of these agents?
Uploaded: 2019-03-11T00:00:00+00:00